INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Edit Your Profile

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Journal

publication venue for

Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer. 29:922-928. 2019
Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study. 28:925-931. 2018
A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. 27:668-674. 2017
An Organizational Guideline for Gynecologic Oncology Services. 25:551-558. 2015
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability. 24:664-669. 2014
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability (Retracted Article). 23:1010-1015. 2013
Surgical Outcome of Robotic Surgery in Morbidly Obese Patient With Endometrial Cancer Compared to Laparotomy. 22:76-81. 2012
Protocol Development for Ovarian Cancer Treatment in Kenya A Brief Report. 21:424-427. 2011
Teaching Cervical Cancer Surgery in Low- or Middle-Resource Countries. 20:1604-1608. 2010
Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer. 20:772-780. 2010
The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas. 19:58-64. 2009
The impact of obesity on surgery in gynecological oncology: a review. 16:944-952. 2006
A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer. 16:47-53. 2006
A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer. 16:47-53. 2006
The impact of obesity on surgery in gynecological oncology: A review. 16:944-952. 2006
Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy. 16:278-285. 2006
Uterine papillary serous carcinoma: evaluation. of multimodality treatment with abdominopelvic radiotherapy and chemotherapy. 16:278-285. 2006
127 High Throughput SNP Analysis of Brca1/2 Associated DNA Mismatch Repair Genes in Ovarian Cancer: Predicting Response to Chemotherapy and Survival. 14:38. 2004
159 Comparative Gene Expression Between Brca-Dependent and Sporadic Serous Ovarian Cancer: is The DNA Repair Pathway A Common Link?. 14:46-47. 2004
812 How Many Gynaecologic Oncologists Are Needed for Your Community. What Are The Differences in Gynecologic Oncology Manpower in Different Regions in Canada and United States. 14:224. 2004
Optimal Surgical Cytoreduction in Patients With Stage III and Stage IV Endometrial Carcinoma: A Study of Survival and Morbidity. 13:28. 2003
Use of CA-125 and ultrasound in high-risk women. 12:86-91. 2002
Evaluation of the Pfannenstiel incision for radical abdominal hysterectomy with pelvic and para-aortic lymphadenectomy. 9:418-420. 1999
Radical hysterectomy for cervical cancer: Hysterectomy before pelvic lymphadenectomy or vice versa?. 9:307-311. 1999
Use of CA-125 and ultrasound in high-risk women. 12:86-91.
Vulvar intra-epithelial neoplasia-treatment outcome. 6:145-148.
Urinary diversion after exenterative surgery: continent conduit remains my ideal approach 2021
Erratum: Risk factors for ovarian cancers with and without microsatellite instability (International Journal of Gynecological Cancer (2013) 23 (1010-1015)) 2014

category

OBSTETRICS & GYNECOLOGY Category
ONCOLOGY Category

International Standard Serial Number (ISSN)

1048-891X

Electronic International Standard Serial Number (EISSN)

1525-1438

journal abbreviation

INT J GYNECOL CANCER